Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1986 Nov;66(2):472–480.

Functional C8 associated with human platelets.

F Tedesco, P Densen, M A Villa, G Presani, L Roncelli, V E Rosso di san Secondo
PMCID: PMC1542537  PMID: 3815901

Abstract

Haemolytic assay for C8 revealed its association in functionally active form with washed human platelets. Platelet-bound C8 haemolytic activity was inhibited by F(ab')2 anti-C8 and was undetectable in the platelet suspension obtained from three C8 deficient patients. Incubation of platelets from C8 deficient individuals in normal plasma did not restore C8 haemolytic activity, indicating that platelets do not absorb C8 from plasma in vitro during platelet preparation. Thrombin, a mediator of the platelet release reaction, did not induce the release of C8 from normal platelets. Conversely, lysis of EAC1-7.9 by platelet bound C8 was not accompanied by release of beta-thromboglobulin or serotonin from the platelets. C8 was detected in a homogenate prepared from platelets as well as in the supernatant collected after high speed centrifugation of the homogenate. The association of C8 with platelets as an individual component rather than as part of the C5b-9 membrane-attack complex was supported by the following evidence: platelet bound C8 eluted from a Sephacryl S-200 column at the same volume as C8 from normal human serum; F(ab')2 anti-C8, but not F(ab')2 anti-C5, inhibited platelet C8 activity; the platelet homogenate, which lysed EAC1-7.9, had no effect on EAC43 which are susceptible to the lytic activity of the C5b-9 complex.

Full text

PDF
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biesecker G., Müller-Eberhard H. J. The ninth component of human complement: purification and physicochemical characterization. J Immunol. 1980 Mar;124(3):1291–1296. [PubMed] [Google Scholar]
  2. Clark R. A., Klebanoff S. J. Myeloperoxidase-mediated platelet release reaction. J Clin Invest. 1979 Feb;63(2):177–183. doi: 10.1172/JCI109287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Kenney D. M., Davis A. E., 3rd Association of alternative complement pathway components with human blood platelets: secretion and localization of factor D and beta 1H Globulin. Clin Immunol Immunopathol. 1981 Dec;21(3):351–363. doi: 10.1016/0090-1229(81)90224-5. [DOI] [PubMed] [Google Scholar]
  4. Lachmann P. J., Thompson R. A. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9. J Exp Med. 1970 Apr 1;131(4):643–657. doi: 10.1084/jem.131.4.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mustard J. F., Perry D. W., Ardlie N. G., Packham M. A. Preparation of suspensions of washed platelets from humans. Br J Haematol. 1972 Feb;22(2):193–204. doi: 10.1111/j.1365-2141.1972.tb08800.x. [DOI] [PubMed] [Google Scholar]
  6. Polley M. J., Nachman R. L., Weksler B. B. Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med. 1981 Feb 1;153(2):257–268. doi: 10.1084/jem.153.2.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Polley M. J., Nachman R. The human complement system in thrombin-mediated platelet function. J Exp Med. 1978 Jun 1;147(6):1713–1726. doi: 10.1084/jem.147.6.1713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ross S. C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984 Sep;63(5):243–273. [PubMed] [Google Scholar]
  9. Schmaier A. H., Smith P. M., Colman R. W. Platelet C1- inhibitor. A secreted alpha-granule protein. J Clin Invest. 1985 Jan;75(1):242–250. doi: 10.1172/JCI111680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Steckel E. W., York R. G., Monahan J. B., Sodetz J. M. The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure. J Biol Chem. 1980 Dec 25;255(24):11997–12005. [PubMed] [Google Scholar]
  11. Tedesco F., Bardare M., Giovanetti A. M., Sirchia G. A familial dysfunction of the eight component of complement (C8). Clin Immunol Immunopathol. 1980 Jun;16(2):180–191. doi: 10.1016/0090-1229(80)90202-0. [DOI] [PubMed] [Google Scholar]
  12. Tedesco F., Densen P., Villa M. A., Petersen B. H., Sirchia G. Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules. J Clin Invest. 1983 Feb;71(2):183–191. doi: 10.1172/JCI110758. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tedesco F., Silvani C. M., Agelli M., Giovanetti A. M., Bombardieri S. A lupus-like syndrome in a patient with deficiency of the sixth component of complement. Arthritis Rheum. 1981 Nov;24(11):1438–1440. doi: 10.1002/art.1780241119. [DOI] [PubMed] [Google Scholar]
  14. Tedesco F., Silvani C. M., Sirchia G. Effect of complement activation on granulocyte adherence to nylon fibers: inhibitory activity of C567 complex. Clin Immunol Immunopathol. 1981 Feb;18(2):176–186. doi: 10.1016/0090-1229(81)90023-4. [DOI] [PubMed] [Google Scholar]
  15. Tedesco F., Tovo P. A., Tamaro G., Basaglia M., Perticarari S., Villa M. A. Selective C3 deficiency due to C3 nephritic factor in an apparently healthy girl. Ric Clin Lab. 1985 Oct-Dec;15(4):323–329. doi: 10.1007/BF03029146. [DOI] [PubMed] [Google Scholar]
  16. Thompson R. A., Lachmann P. J. Reactive lysis: the complement-mediated lysis of unsensitized cells. I. The characterization of the indicator factor and its identification as C7. J Exp Med. 1970 Apr 1;131(4):629–641. doi: 10.1084/jem.131.4.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wautier J. L., Tobelem G. M., Peltier A. P., Caen J. P. C1 and human platelets. II. Detection by immunological methods and role. Immunology. 1976 Apr;30(4):459–465. [PMC free article] [PubMed] [Google Scholar]
  18. Zimmerman T. S., Kolb W. P. Human platelet-initiated formation and uptake of the C5-9 complex of human complement. J Clin Invest. 1976 Jan;57(1):203–211. doi: 10.1172/JCI108261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Zimmerman T. S., Spiegelberg H. L. Pneumococcus-induced serotonin release from human platelets. Identification of the participating plasma/serum factor as immunoglobulin. J Clin Invest. 1975 Oct;56(4):828–834. doi: 10.1172/JCI108161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zucker M. B., Mosesson M. W., Broekman M. J., Kaplan K. L. Release of platelet fibronectin (cold-insoluble globulin) from alpha granules induced by thrombin or collagen; lack of requirement for plasma fibronectin in ADP-induced platelet aggregation. Blood. 1979 Jul;54(1):8–12. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES